Business
Board Restructuring
Board Restructuring.
About this update from Iconic Labs Plc
[{"type":"text","content":"\n \nRNS Number : 5001E WideCells Group PLC 18 October 2018 \n\n18 October 2018\nWideCells Group PLC ('WideCells Group' or 'the Group') \nBoard Restructuring \n \nWideCells Group PLC, the healthcare services group focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is restructuring its board as part of a wider programme to minimise costs, refocus its strategy on the core operational divisions and target revenue growth.\n \nDavid Bridgland, Chief Financial Officer, has stepped down from his board position but will serve out his notice period until the end of the year; a non-board financial controller will be recruited. Professor Peter Hollands has also stepped down from his board position but will remain as a director of WideCells Storage and Research division as well as the Group's Chief Scientific Officer. \n \nChairman, Peter Presland, will take on additional responsibilities until the Group has stabilised, overseeing corporate matters, financial management and relationships with investors and advisors. This will enable CEO, João Andrade, to focus on sales and business development, prioritising revenue generation. \n \nWideCells Group Chairman, Peter Presland, said, \"I'd like to thank David for his work with the Group and I wish him all the best in his future endeavours. Professor Hollands will continue to be an invaluable asset to us as the Group's Chief Scientific Officer, and I'd like to extend my special gratitude to him for his work on the board. \n \n\"Moving forward, I'll be taking a more active role in the financial management of the Group and additional corporate responsibilities to free up time for our CEO, João Andrade, to focus on what he is really good at - sales and business growth.\"\n \n**ENDS**\n \nFor further information, please visit the Group's website www.widecellsgroup.com, follow us on Twitter @WideCells_Group or contact:\n \n\n\n\n\nWideCells Group PLC\n\n\nCEO - João Andrade\n\n\nTel: +351 919 033 171\nE: [email protected]\n\n\n\n\nShard Capital Partners LLP\n\n\nBroker - Damon Heath & Erik Woolgar\n\n\nTel: +44 (0) 20 7186 9950\n\n\n\n\nSt Brides Partners Limited\n\n\nPR - Priit Piip & Isabel de Salis\n\n\nTel: +44 (0) 20 7236 1177\n\n\n\n\n \nNotes to...